Xinjiang Zhongtai Chemical Co., Ltd. (SHE:002092)
China · Delayed Price · Currency is CNY 7.11
-0.14 (-1.93%)
At close: Feb 13, 2026
SHE:002092 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 27,931 | 29,178 | 36,334 | 50,960 | 62,096 | 83,711 |
Other Revenue | 945.11 | 945.11 | 783.67 | 702.16 | 797.77 | 503.36 |
| 28,876 | 30,123 | 37,118 | 51,662 | 62,893 | 84,215 | |
Revenue Growth (YoY) | -1.53% | -18.84% | -28.15% | -17.86% | -25.32% | 1.29% |
Cost of Revenue | 23,786 | 25,464 | 34,033 | 44,917 | 54,157 | 79,383 |
Gross Profit | 5,089 | 4,660 | 3,085 | 6,745 | 8,736 | 4,831 |
Selling, General & Admin | 3,260 | 3,237 | 3,417 | 3,628 | 3,219 | 3,231 |
Research & Development | 367.08 | 377.4 | 261.37 | 444.03 | 76.65 | 27.17 |
Other Operating Expenses | 579.4 | 473.73 | 394.41 | 527.7 | 430.24 | 204.09 |
Operating Expenses | 4,250 | 4,083 | 4,269 | 4,627 | 3,835 | 3,538 |
Operating Income | 838.96 | 576.42 | -1,184 | 2,119 | 4,901 | 1,294 |
Interest Expense | -1,004 | -1,027 | -1,176 | -1,155 | -1,296 | -1,157 |
Interest & Investment Income | 70.43 | 48.4 | 124.34 | 461.14 | 156.99 | 43.85 |
Currency Exchange Gain (Loss) | -6.87 | -6.87 | -24.75 | 56.09 | -14.07 | -5.48 |
Other Non Operating Income (Expenses) | -65.75 | -31.55 | -183.93 | -85.8 | -80.36 | -74.19 |
EBT Excluding Unusual Items | -166.9 | -440.25 | -2,445 | 1,395 | 3,667 | 100.48 |
Impairment of Goodwill | -0.29 | -0.29 | -57.03 | - | - | - |
Gain (Loss) on Sale of Investments | -317.93 | -295.8 | -485.04 | -4.62 | 19.57 | -8.81 |
Gain (Loss) on Sale of Assets | 4.31 | 3.25 | 3.84 | 6.28 | 6.24 | 15.73 |
Asset Writedown | -407.6 | -404.26 | -287.11 | -1.23 | -114.48 | -2.59 |
Other Unusual Items | 11.99 | 11.99 | 49.03 | 14.95 | 67.7 | 63.68 |
Pretax Income | -876.43 | -1,125 | -3,221 | 1,411 | 3,646 | 168.5 |
Income Tax Expense | 233.67 | 157.79 | -35.41 | 251.72 | 572.98 | 214.82 |
Earnings From Continuing Operations | -1,110 | -1,283 | -3,186 | 1,159 | 3,073 | -46.32 |
Minority Interest in Earnings | 302.44 | 306.64 | 320.47 | -382.77 | -325.49 | 190.85 |
Net Income | -807.67 | -976.52 | -2,865 | 776.28 | 2,748 | 144.53 |
Net Income to Common | -807.67 | -976.52 | -2,865 | 776.28 | 2,748 | 144.53 |
Net Income Growth | - | - | - | -71.75% | 1801.27% | -62.26% |
Shares Outstanding (Basic) | 2,575 | 2,576 | 2,576 | 2,576 | 2,325 | 2,148 |
Shares Outstanding (Diluted) | 2,575 | 2,576 | 2,576 | 2,576 | 2,325 | 2,148 |
Shares Change (YoY) | -0.04% | 0.00% | 0.01% | 10.76% | 8.28% | 0.04% |
EPS (Basic) | -0.31 | -0.38 | -1.11 | 0.30 | 1.18 | 0.07 |
EPS (Diluted) | -0.31 | -0.38 | -1.11 | 0.30 | 1.18 | 0.07 |
EPS Growth | - | - | - | -74.49% | 1655.87% | -62.28% |
Free Cash Flow | 285.78 | 2,945 | -105.01 | 27.52 | 2,808 | 4,954 |
Free Cash Flow Per Share | 0.11 | 1.14 | -0.04 | 0.01 | 1.21 | 2.31 |
Dividend Per Share | - | - | - | 0.100 | 0.120 | 0.010 |
Dividend Growth | - | - | - | -16.67% | 1100.00% | -37.50% |
Gross Margin | 17.63% | 15.47% | 8.31% | 13.06% | 13.89% | 5.74% |
Operating Margin | 2.90% | 1.91% | -3.19% | 4.10% | 7.79% | 1.54% |
Profit Margin | -2.80% | -3.24% | -7.72% | 1.50% | 4.37% | 0.17% |
Free Cash Flow Margin | 0.99% | 9.78% | -0.28% | 0.05% | 4.46% | 5.88% |
EBITDA | 4,252 | 3,654 | 1,447 | 4,580 | 7,182 | 3,271 |
EBITDA Margin | 14.72% | 12.13% | 3.90% | 8.87% | 11.42% | 3.88% |
D&A For EBITDA | 3,413 | 3,078 | 2,631 | 2,461 | 2,281 | 1,977 |
EBIT | 838.96 | 576.42 | -1,184 | 2,119 | 4,901 | 1,294 |
EBIT Margin | 2.90% | 1.91% | -3.19% | 4.10% | 7.79% | 1.54% |
Effective Tax Rate | - | - | - | 17.84% | 15.71% | 127.49% |
Revenue as Reported | 28,876 | 30,123 | 37,118 | 51,662 | 62,893 | 84,215 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.